Sharecast
United Kingdom
Italian
Spanish
Portuguese
French
German
Chinese (Sim.)
Chinese (Tra.)
Russian
Danish
Croatian
Dutch
Finnish
Japanese
Swedish
Norwegian
Polish
Romanian
Serbian
Turkish
Indonesian
Bosnian
Bulgarian
Catalan
Czech
Greek
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Cebuano
Chichewa
Corsican
sharecast
News
Overview
Overview
Home
UK Shares
UK SHARES
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
MARKET DATA
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
FUNDS
Funds Centre
Managers
News
Brokers
BROKERS
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
SPREAD BET
Learn
Strategies
Economic calendar
Portfolio
Watchlist
More
Home
UK Shares
Home
Results
Broker Views
Director Dealings
IPO Centre
Company Diary
Regulatory News
Company A-Z
Market Data
Overview
Indices
Currencies
Commodities
Gilts
ETFS
Bonds
Sharecast News
Cryptocurrencies
Technical Analysis
Active Trader
Funds
Funds Centre
Managers
News
Brokers
Home
Forex
Shares
Binary Options
CFDs
Futures
Options
Spread Betting
Learn on finance
Spread Bet
Learn
Strategies
Economic calendar
Portfolio
Watchlist
Pharmaceuticals & Biotechnology (NMX4570)
22,562.31
17:09 14/03/25
0.73%
162.49
High / Low
22,606.08 / 22,339.21
Open / Close
22,399.82 / 22,562.31
Advertising
News
Overview
Latest webfg news
London close: Stocks mixed on corporate earnings, Trump tariff threats
27 Feb
Genus's bottom line hit by write-downs
27 Feb
hVIVO acquires biological material storage specialist Cryostore
27 Feb
Pharma veteran Ciaffoni to take CEO reins at Indivior
27 Feb
Annual sales, profits jump at Haleon
27 Feb
London close: Stocks rise as investors look to Nvidia earnings
26 Feb
Ondine appoints new finance, operations chief
26 Feb
Shares in Hikma fall after results disappoint
26 Feb
AstraZeneca's camizestrant shows promise in breast cancer trial
26 Feb
ValiRx ends evaluation project with Imperial College London
24 Feb
Indivior's opioid addiction treatment gets FDA label change approval
24 Feb
London close: Stocks little changed after UK data dump
21 Feb
GSK seen as potential target for activist investors
21 Feb
Proteome secures $1m-plus contract with US biopharma firm
21 Feb
Poolbeg shares slide as Hookipa terminates takeover talks
21 Feb
London close: Stocks slip as US jobless claims rise
20 Feb
Indivior ends year better than expected, flags tough 2025
20 Feb
Eco Animal Health sells non-core product lines
19 Feb
OptiBiotix launches new US product with Daily Nouri
18 Feb
Hvivo signs £2m contract with new biopharma client
17 Feb
1
2
»
«
2024-11
2024-12
2025-01
2025-02
2025-03
»
Loading:
Login with Facebook
Login with Google
o
Log in
Remember me
Forgot password?
Don’t have an account?
Sign In